Physician profile
Daniel C Lee
NPI 1790890390
$1,385.10
in general payments reported to CMS, 2019-2025
9 companies · $609 in 2025
The $609 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $144 · 2021: $16.06 · 2023: $472 · 2024: $143 · 2025: $609.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,197 · Gift: $28.21.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,196.73 |
| Gift | $28.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $600.28 | 2024-2025 | Impella |
| Bolton Medical INC | $264.68 | 2023 | Relay Thoracic Stent-Graft With Plus Delivery System, Treo Abdominal Stent-Graft System |
| Siemens Medical Solutions USA, INC. | $178.15 | 2023 | |
| Boston Scientific Corporation | $144.10 | 2019 | |
| Zimmer Biomet Holdings, INC. | $115.25 | 2024 | |
| Corcym INC | $37.20 | 2025 | Mi Detach - Aortic Cross Clamp - Delivery System Kit |
| Ethicon US, LLC | $29.38 | 2023 | Evarrest, Prolene |
| Getinge USA Sales, LLC | $16.06 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.